Skip to main content
logo
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.220
-0.020 (-1.61%)
At close: Aug 28, 2026, 4:00 PM EDT
1.225
+0.005 (0.41%)
After-hours: Aug 28, 2026, 7:30 PM EDT

PMV Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
15.6216.3320.924.2525.0521.8
Research & Development
64.0469.8857.9355.8951.9936.49
Operating Expenses
79.6786.2178.8380.1377.0458.29
Operating Income
-79.67-86.21-78.83-80.13-77.04-58.29
Interest & Investment Income
4.486.3410.6611.173.630.45
Other Non Operating Income (Expenses)
-0.01-0.05-0.0200.090.02
EBT Excluding Unusual Items
-75.2-79.91-68.19-68.96-73.33-57.82
Merger & Restructuring Charges
---0.6---
Asset Writedown
---6.02---
Pretax Income
-75.2-79.91-74.81-68.96-73.33-57.82
Income Tax Expense
0.02-2.17-16.10-0.010.02
Net Income
-75.22-77.74-58.71-68.96-73.32-57.85
Net Income to Common
-75.22-77.74-58.71-68.96-73.32-57.85
Net Income Growth
------
Shares Outstanding (Basic)
535352484645
Shares Outstanding (Diluted)
535352484645
Shares Change
2.69%1.87%7.42%5.31%1.01%214.23%
EPS (Basic)
-1.41-1.48-1.14-1.44-1.61-1.28
EPS (Diluted)
-1.41-1.48-1.14-1.44-1.61-1.28
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-71.28-73.61-51.94-56.62-71.74-47.92
Free Cash Flow Per Share
-1.34-1.40-1.01-1.18-1.57-1.06
EBITDA
-79.54-86.07-77.68-78.88-76.73-57.99
D&A For EBITDA
0.120.131.141.260.320.31
EBIT
-79.67-86.21-78.83-80.13-77.04-58.29
SEC Filings: 10-K · 10-Q